Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review.

Clinical Drug Investigation
Chang-Yu Hsieh, Tsen-Fang Tsai

Abstract

Idiosyncratic drug-induced neutropenia (DIN) is a rare, potentially fatal adverse reaction. A literature search was performed on Pubmed and Embase, targeting articles indicating neutropenia as a complication during the treatment of non-neoplastic dermatological disorders. In 66 identified articles, the common incriminated drugs included conventional oral immunomodulators, topical cytotoxic agents, antibacterials, antifungals, biologics and targeted synthetic disease-modifying antirheumatic drugs, non-steroidal anti-inflammatory drugs, and retinoids, with dapsone being reported most often. The duration of drug exposure before the diagnosis of neutropenia varied, but mostly ranged from days to weeks. The majority of patients recovered after drug discontinuation and supportive management including antibiotics and granulocyte colony-stimulating factor, but fatal cases were reported. The proposed pathogenesis of DIN consists of direct drug toxicity and immune-mediated reaction. Certain genetic variants, individual variability in enzyme efficiency, and concomitant use of other drugs may increase the risk of DIN. Being familiar with the most commonly implicated agents and risk factors helps early identification and prompt management o...Continue Reading

References

Sep 1, 1978·Annals of Internal Medicine·G P StoehrW J Taylor
Feb 1, 1992·The British Journal of Dermatology·N S Ryder
Feb 1, 1988·Journal of the American Academy of Dermatology·M Waisman
Apr 1, 1986·Burns, Including Thermal Injury·P WilsonP Raine
Mar 6, 1986·The New England Journal of Medicine·S W MamusE D Zanjani
Dec 1, 1985·Journal of the American Academy of Dermatology·A J Wishner, P B Milburn
Aug 1, 1984·Hospital Practice·M Turck
Nov 1, 1994·Journal of the American Academy of Dermatology·M J KovacsM Bourcier
Sep 1, 1994·Clinical and Experimental Dermatology·K E McKenna, D Burrows
Nov 1, 1995·General Pharmacology·M D Coleman
May 1, 1997·Journal of the American Academy of Dermatology·E J Primka, C Camisa
May 20, 1998·Journal of the American Academy of Dermatology·A K GuptaN H Shear
Aug 26, 1998·Journal of Clinical Gastroenterology·G BhatC Berkelhammer
Dec 8, 1998·Journal of the American Academy of Dermatology·D L Ornstein, P Ely
Apr 25, 2000·Lancet·W Stock, R Hoffman
Feb 24, 2001·The Annals of Pharmacotherapy·A J Dixon, G C Wall
Jul 17, 2001·Annals of the Rheumatic Diseases·M CutoloR H Straub
Sep 25, 2001·Journal of the American Academy of Dermatology·C Aguilar, K K Mueller
Aug 14, 2002·The British Journal of Dermatology·J Berth-JonesR A C Graham-Brown
Jun 6, 2003·The British Journal of Dermatology·T A ChaveP E Hutchinson
Jul 7, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·T K HoffmannP Lehmann
Nov 18, 2005·Clinical Therapeutics·Kelly Smith, James J Leyden
Aug 16, 2006·Journal of the American Academy of Dermatology·Akash A PatelCalvin O McCall
Oct 18, 2006·Archives of Dermatology·Laura Y McGirtLisa A Beck
Nov 16, 2006·Annals of the Rheumatic Diseases·S RajakulendranC Deighton
May 2, 2007·Annals of Internal Medicine·Frank AndersohnEdeltraut Garbe
Sep 12, 2007·Pediatric Dermatology·Mehmet Akif OzdemirEsad Koklu
Oct 6, 2007·The British Journal of Dermatology·R Rios-FernándezN Ortego-Centeno
May 7, 2008·Annales de dermatologie et de vénéréologie·I LahbabiJ Chevrant-Breton
Jul 9, 2008·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Giorgio EleftheriouRoberta Sebastiano
Mar 18, 2009·Archives of Dermatology·Asha ShahVictoria P Werth
Apr 8, 2009·Journal of Burn Care & Research : Official Publication of the American Burn Association·Frederick W Fuller
Jan 9, 2010·Clinical and Experimental Dermatology·J JordanD Wilsmann-Theis
Apr 19, 2011·Expert Review of Hematology·Emmanuel AndrèsFrédéric Maloisel
Jun 26, 2012·Alimentary Pharmacology & Therapeutics·T BessissowG Van Assche
Nov 1, 2012·Indian Journal of Pharmacology·Baisakhi LahaAvijit Hazra
Mar 26, 2013·Journal of Clinical Pharmacy and Therapeutics·O M Al-Quteimat, M A Al-Badaineh
Nov 2, 2013·Indian Journal of Dermatology, Venereology and Leprology·Rashmi SarkarVijay K Garg
Dec 18, 2013·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Roy Anthony OrdenSarbjit S Saini
Nov 27, 2014·Expert Opinion on Drug Metabolism & Toxicology·Alexander Johnston, Jack Uetrecht

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
M Takeda, H Endou
Virchows Archiv : an International Journal of Pathology
Gary L Bratthauer, Fattaneh A Tavassoli
Expert Opinion on Drug Safety
Mahmoud Loghman-AdhamMatthias Meier
© 2021 Meta ULC. All rights reserved